Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | estrogen receptor 1 | Starlite/ChEMBL | References |
Homo sapiens | estrogen receptor 2 (ER beta) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | estrogen receptor 2 (ER beta) | 495 aa | 418 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0254 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0764 | 0.6669 | 0.6669 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.1019 | 1 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0254 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.1019 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1019 | 1 | 1 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0254 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 157 nM | Inhibitory concentration against human ER beta expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand | ChEMBL. | 15456246 |
IC50 (binding) | = 157 nM | Inhibitory concentration against human ER beta expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand | ChEMBL. | 15456246 |
IC50 (binding) | = 157 nM | Binding affinity to ERbeta | ChEMBL. | 17459530 |
IC50 (binding) | = 2765 nM | Inhibitory concentration against human ER alpha expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand | ChEMBL. | 15456246 |
IC50 (binding) | = 2765 nM | Inhibitory concentration against human ER alpha expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand | ChEMBL. | 15456246 |
Selectivity (binding) | = 18 | Selectivity fold for estrogen receptor beta over estrogen receptor alpha | ChEMBL. | 15456246 |
Selectivity (binding) | = 18 | Selectivity fold for estrogen receptor beta over estrogen receptor alpha | ChEMBL. | 15456246 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.